Introduction and Aims. Alcohol-related morbidity is estimated to range from 10-38% of the presentations to hospital emergency departments. This study aims to investigate the actual management process for alcohol-related presentations in a teaching hospital in Australia. Design and Methods. Retrospective audit was conducted on the electronic medical records of 210 presentations with a primary or secondary diagnosis of 'alcohol use disorder' at discharge between November 2016 and February 2017. Six key management steps were investigated: identification of alcohol use disorder, documentation, thiamine, alcohol withdrawal assessment, benzodiazepine for alcohol withdrawal and referral to the drug and alcohol consultation liaison service. Results. Of all the 210 presentations, 77.1% (162) were identified with alcohol use disorder in the initial assessments; 64.3% (135) were documented with alcohol use history, 49.5% (104) were prescribed with thiamine, 48.1% (101) were assessed with the alcohol withdrawal scale, 41% (86) were prescribed with benzodiazepine for alcohol withdrawal and only 38.6% (81) were referred to the drug and alcohol consultation liaison service. Only 8.6% (18) of the initial presentations were directly related to alcohol. These presentations had a higher completion rate in each of the six steps than those (91.4%, 192) not directly related to alcohol. Only 6.2% (13) were formally screened for alcohol use. Discussion and Conclusions. The findings suggest a need to improve the alcohol management practice in the hospital. Routine use of an alcohol screening tool can enable early identification of the alcohol use disorder and to improve the management of this problem in the hospital.
Introduction
Alcohol is one of the top five risk factors for disease and disability that caused 3.3 million deaths annually [1, 2] . In Australia, alcohol caused more than 5500 deaths and 150 000 hospitalisations in 2010 [3] . unidentified [8] . As alcohol withdrawal and its complications such as seizures may occur 6 h after the last drink [9] , failure in identification of alcohol use disorder (AUD) can lead to unexpected acute alcohol withdrawal. This can further complicate emergency assessment and diagnosis, causing harm to patients [10] .
Early identification of AUD is essential for the medical staff to determine optimal clinical management of the patients [11] . An effective way is to use an alcohol screening tool to identify and assess whether alcohol is harming a person's health or is likely to cause harm in the future. Although there are validated, formal alcohol screening tools available such as Alcohol Use Disorders Identification Test [12] , the Cut-down, Annoyed, Guilt, Eye-opener [13] and the Paddington Alcohol Test [14] , the use of these tools remains unsatisfactory in Australian hospitals [15] . This results in a significant proportion of patients with AUD unscreened or undiagnosed, exposing them to the risk of developing alcohol withdrawal symptoms or complications. A recent Australian study evaluated the effectiveness of a routine screening and triage tool for alcohol withdrawal syndrome [16] . The study specifically measured the completion rate of identification of alcohol withdrawal syndrome, documentation of alcohol use and appropriate withdrawal management before and after the intervention. It found that after the use of the tool, there was a significant increase in the rate of documentation of alcohol use from 35.4% preintervention to 55.2% post-intervention. The rate of appropriate management also increased significantly from 31.8% to 80% [16] .
When AUD is suspected, assessment and documentation of alcohol use history should be conducted. This includes information such as duration, quantity, pattern of use, previous attempts to cut down alcohol intake or psychosocial impact [17, 18] . Research on documentation of alcohol use is sparse and is not specific to patients with AUD. One study of documentation pattern of alcohol use in electronic medical records (eMR) in primary care found that although 56% of the eMR had quantitative documentation of alcohol use, only 26% had qualitative descriptions of this use [19] . Another similar study in hospital records for cancer patients found that 57% of the documentation of alcohol use history was poorly described as social, occasional or moderate drinkers [20] . Therefore, there is a need to assess the documentation of alcohol use history for patients with AUD.
Due to prolonged heavy alcohol consumption, patients with AUD suffer from thiamine deficiency [21] . Therefore, once identified, these patients should be provided with thiamine to prevent Wernicke's encephalopathy, an acute neurological syndrome caused by thiamine deficiency [21] [22] [23] . The earlier thiamine is started, the faster the patient will recover [24] . Route of thiamine administration can be oral or parenteral. A retrospective medical record audit study found that among 226 patients, 89% (201) were prescribed with oral thiamine [25] . However, for patients at risk of alcohol withdrawal, only 4.5 mg of thiamine can be absorbed orally from any dose over 30 mg [26] ; therefore, parenteral thiamine is the standard of care [21, 27] .
To assess severity of alcohol withdrawal and to guide therapy appropriately, several validated scales can be used [9] . The Alcohol Withdrawal Scale (AWS) requires less reliance on patients' response by assessing four physiological indicators (pulse, body temperature, sweating and tremor) and five mental or psychopathological symptoms (agitation, anxiety, tactile disturbances, disorientation and hallucination) common to alcohol withdrawal [28] . According to the Clinical Institute Withdrawal Assessment for Alcohol scale in its revised version, the severity of alcohol withdrawal should be estimated by observation with patient participation [9] . In case of lacking patient cooperation, other tools can be used, such as the Richmond AgitationSedation Scale which is generally applicable to intensive care patients [9, 29] .
To prevent progression to a more severe withdrawal, benzodiazepine is recommended to be used early in the management of alcohol withdrawal [17] . Despite the fact that within the first 2 days of withdrawal, benzodiazepine reduces the incidence of seizures by up to 84% and prevent the development of delirium tremens [9] , a previous study found that only 37% of patients with AUD were prescribed with benzodiazepine for alcohol withdrawal management [30] .
To provide effective advice on inpatient withdrawal management, assess patients' readiness to change alcohol consumption behaviour and assist them to meet their goal, it is recommended that clinicians refer every patient with AUD to the hospital-based Drug and Alcohol Consultation Liaison (DA-CL) specialist service [17] . However, it is found that in practice, only 51% of the patients with AUD were referred to the specialist treatment services including drug and alcohol service [30] and only 27% of ED staff provided these patients with formal referral to the outpatient alcohol service [31] .
With the above prior knowledge, this research aims to understand and identify gaps in the actual management process of patients with AUD in a teaching hospital in Australia. Specifically, six key steps in the management of patients with AUD in hospitals were examined: identification of AUD, documentation of alcohol use history, thiamine use, alcohol withdrawal assessment, benzodiazepine for treatment of alcohol withdrawal and referral to the DA-CL service.
Methods

Study design
The study was conducted in a teaching hospital in New South Wales, Australia. To allow the inclusion of any alcohol-related presentations, the diagnosis-related group 'AUD' acquired on discharge was used to identify these presentations. This umbrella term includes both apparent alcohol induced symptoms (e.g. intoxication) and complications (e.g. alcoholic pancreatitis), of which initial disclosure are more difficult. Three hundred and sixty-seven consecutive patient presentations with a primary or secondary discharge diagnosis of AUD between 15 November 2016 and 15 February 2017 were identified, retrospectively.
Among these consecutive presentations, 210 (57.2%) presentations incurred by 199 patients were randomly selected. These included patients who were triaged and assessed in the ED, those who were directly admitted to the hospital wards and inter-hospital transfers. The randomization was performed in the IBM SPSS Statistics. As no paper file was used in the study hospital, all the patient information was extracted from the eMR for this audit research.
Audit of one patient record requires 30-min manual work by the advanced trainee who could only afford half a day per week for research. That totals up to 105 h of work. Given this constraint, the sample size may seem small, however it accounts for 57.2% of the total population.
An investigation of hospital re-presentation, readmission and attendance to the community-based Drug and Alcohol Service was also conducted 17 months after patient discharge.
The project was approved by the hospital authority as meeting the requirements for quality assurance/audit and therefore it did not require consideration by the Human Research Ethics Committees.
Development of the audit protocol for extraction of data variables from the medical records
A collaborative, consensus-based, multi-disciplinary approach was used to complete this research. In total, 17 project meetings were held among the authors. Of these meetings, three were focus group discussions to develop a data extraction scheme in order to ensure that the extracted data can address our research aim. The first focus group discussion involved three clinician authors to develop an initial list of 16 data variables for extraction. The second focus group involved six clinicians and a researcher in epidemiology to review and expand the list to 21 variables. The third focus group involved five clinicians to further scrutinise the data variables and one more variable-'number of AWS observations in the first 24 h after presentation'-was added. A coding scheme, including the variables and their values, was developed by data extractor 1, then validated by six clinicians. For example, three possible values for the variable 'thiamine administration' were parenteral thiamine, oral thiamine and no drug prescribed.
The 21 data variables were grouped into seven categories:
• Patient characteristics include eight variables: gender, age, length of stay, admission specialty, admission ward, triage code, presenting problem and postcode.
• Identification of AUD includes three variables: screening tool used to assess the severity of AUD, whether AUD was identified at ED triage and who (job role) identified and documented AUD.
• Documentation of alcohol use history includes one variable: who (job role) documented detailed history of AUD (e.g. duration, quantity, pattern of use, previous attempts to cut down alcohol intake and social impact).
• Thiamine includes one variable: thiamine administration. Thiamine assists with nutritional deficiencies associated with AUD which, if untreated, may lead to Wernicke's encephalopathy [23] .
• AWS assessment includes six variables: whether AWS was started prior to or after the medical officer's assessment, where was AWS first started, time to start AWS from presentation, number of AWS observations in the first 24 h after presentation, maximum AWS score and documented alcohol withdrawal complications.
• Benzodiazepine for alcohol withdrawal includes two variables: type of prescribed benzodiazepine and benzodiazepine regime for alcohol withdrawal. These two variables were used to examine the practice of prescribing benzodiazepine for withdrawal.
• Referral to the DA-CL service includes one variable:
whether the patient was referred to the DA-CL service following the clinical guideline.
Inter-rater agreement
Data extraction was manually conducted by two medical officers with 6 years and 20 months of hospital work experience, respectively. They have sufficient experience of using and extracting information from the eMR. They independently extracted the same 160 data points. A comparison of their records showed a Cohen's Kappa score of 0.96; therefore, adequate agreement was achieved [32] .
Data cleaning and analysis
To ensure data accuracy, nine data validation rules were developed as the criteria to be used to detect inconsistencies, outliers and missing values in a large dataset [33] . Applying validation rules is a wellrecognised method for checking data accuracy. For example, if no AWS was performed, then there should be no record of an AWS score. These rules were then applied to validate the data. Of the 3360 data points manually extracted, 24 errors (0.7%) were identified in 19 patients' records, and were corrected through mapping back to the original eMR. Descriptive statistical analysis was conducted using IBM SPSS Statistics version 21.
Results
Patient characteristics
The 210 presentations were made by 199 patients; 30.2% (60) female and 69.8% (139) male (see Table 1 ). Their age ranged from 14 to 90 years old (mean, 50.6, 95% confidence interval [CI] 48.11, 53.17). On average, a patient stayed in the hospital for 5.9 days (95% CI 4.82, 6.97). It is noteworthy that 91.4% (192) of the 210 presentations had an initial presenting problem not directly related to alcohol, e.g. abdominal pain, reflecting the difficulty of fully disclosing alcohol-related morbidity at the initial presentation. Among all the 210 presentations, 34.2% (72) were admitted by emergency medicine specialty in the short stay area. This is followed by general medicine (18.6%, 39), psychiatry (9%, 19), general surgery (8.1%, 17), gastroenterology (6.7%, 14) and others (23.3%, 49).
Identification and management of patients with alcohol use disorder
Overall, only 6.2% (13) of the 210 presentations were formally assessed by a Mental Health substance use form, as there was no formal alcohol screening tool in place. Figure 1 shows the percentage of patients with AUD in each of the six key management steps. Among all patient presentations, 77.1% (162) were identified with AUD in the initial contacts with medical staff such as ED medical officer, ED nurse or specialty medical officer. The percentage of patients in each key step decreased from 64.3% (135) with a documentation of alcohol use history, 49.5% (104) with thiamine prescribed, 48.1% (101) with AWS assessment to 41% (86) with a prescription of benzodiazepine for alcohol withdrawal.
Of the 210 presentations, 38.6% (81) were referred to the DA-CL service and 61.4% (129) were not. Compared with the non-referred group, the referred one had higher proportion of female (32 Of the 129 non-referred presentations, 83.7% (108/129) received no referral or advice. Although 4.7% (6/129) were advised to contact the Drug and Alcohol Service, no formal referral was made. The rest 6.2% (8/129) of the patients declined referral or were abstinent, 3.9% (5/129) were deceased and 1.6% (2/129) were discharged against medical advice.
Of the 210 presentations, 8.6% (18) had presenting problems directly related to alcohol. These presentations had a higher completion rate of each of the six key steps than those with initial presenting problems not directly related to alcohol (see Figure 1 ).
Management of patients who developed moderate or severe alcohol withdrawal symptoms or complications
The alcohol withdrawal scores showed that 27.6% (58) of all presentations developed moderate or severe withdrawal, and/or withdrawal complications (i.e. seizures, delirium and hallucinations). Table 2 shows that 15.5% of these 58 presentations did not have thiamine and 20.7% received oral thiamine. In the first 24 h since presentation, 32.8% of these did not receive any AWS assessment and 44.8% received one to four assessments. Regarding benzodiazepine regimes, only 1.7% were on loading dose, 34.5% were on symptom-triggered sedation and 31% did not have any prescription of benzodiazepine for withdrawal.
Hospital re-presentation and re-admission
As five patients were deceased in the index presentation, 194 patients were examined for their re-presentation, readmission and attendance to the community-based Drug and Alcohol Service 17 months after discharge. Only 14% (27/194 ) of these patients attended the community-based Drug and Alcohol Service. 
Discussion
This study investigated the practice of identification and management of patients with AUD in an Australian teaching hospital. Medical records of 210 patient presentations with a primary or secondary diagnosis of AUD were audited. The results showed that more than 90% of the presentations were not screened with a formal screening tool. Despite the well-established evidence that early identification can inform optimal clinical management of alcohol-related morbidity [11] , our study showed that more than a fifth of the presentations were not identified with AUD in the initial assessment by the triage nurse, ED medical officer, specialty medical officer or ward nurse. Approximately a third of these presentations did not have documentation of alcohol use history. More than half of them did not have thiamine, AWS assessment and benzodiazepine for alcohol withdrawal. More than 60% were not referred to the DA-CL service.
Our audit found that alcohol screening was conducted for only 6% of the presentations, similar with what was found in a previous study that was also conducted in Australian hospitals [31] . It was also found that 23% of the presentations were not identified with AUD in the initial contact with medical staff, lower than the 30% found in a study conducted in an Australian trauma setting [15] . Identification of AUD and providing brief advice is a cost-effective method to reduce alcohol-related morbidity in EDs [34] . Therefore, almost two thirds of 147 EDs surveyed in UK routinely screen patients' alcohol consumption [35] . Because there is strong evidence of a positive impact of screening on the subsequent management of AUD [36] , there is a need to formally include an alcohol screening tool in the routine assessment in the hospital. (11) Step 1. Identification of AUD
Step 3. Thiamine prescribed
Step 2. Documentation of alcohol use history
Step 4.
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Step 5. Benzodiazepine prescribed
Step 6. Referral made to DA-CL service Figure 1 . Percentage of patients with alcohol use disorder in each of the six key management steps.
According to the local clinical guideline, AWS needs to be conducted second hourly in the first 12 h and four to six hourly for the following 48 h ( Figure S1 , Supporting information), which indicates that at least eight AWS observations should be recorded. Even this number might be an underestimate, our study found a lower number-only one to four AWS observations were recorded for most patients who exhibited moderate or severe withdrawal or developed withdrawal complications.
Thiamine is commonly prescribed to treat patients with alcohol withdrawal. It assists with nutritional deficiencies associated with AUD, which, if left untreated, can lead to Wernicke's encephalopathy [23] . However, for the 58 patients who suffered from moderate or severe withdrawal or developed withdrawal complications, 16% were not prescribed with thiamine and 21% of them received oral thiamine even though parenteral thiamine is recommended as the optimal delivery method [27] .
Our study reveals that there are three benzodiazepine regimes used for treating alcohol withdrawal: loading dose, fixed dose and symptom-triggered sedation. Loading dose regime uses high doses of longer-acting benzodiazepine at the commencement of treatment with no further tapering, to reduce withdrawal-related complications and symptomatology; whereas with fixed dose regime, benzodiazepine is administered at regular intervals and tapered down over few days [17] . The symptom-triggered sedation regime can result in under-treatment by inexperienced staff who may not perform close monitoring of patient response. Because of this, our local guideline recommends using either the fixed or loading regimes (see Figure S2) . Contradictory to this guideline, our study found that among the 58 patients who developed moderate or severe alcohol withdrawal symptoms or complications, only 2% of them were on a loading dose regime. More than one-third of them were sub-optimally prescribed the symptom-triggered benzodiazepine. Unexpectedly, more than 30% of the 210 presentations did not receive any benzodiazepine. According to the local clinical guideline, all of the patients who were diagnosed with AUD should be referred to the hospital DA-CL service. However, in reality, more than 60% of these patients were not referred, missing the opportunity to optimise care and provide relevant education to these patients [37] .
Limitation
There is a potential under-reporting of AUD in the eMR because the study scope and resource limitation did not allow the assessment of the completeness of the eMR in the study hospital. However, the number of referrals to the DA-CL was validated by comparing the data extracted from the eMR and the referral list kept by the DA-CL. The comparison found that 22 referrals recorded by the DA-CL were not actually documented in the eMR. These 22 referrals were then added to the audit results.
The methodology of retrospective audit of eMR was also limited by the completeness and accuracy of the records at the data entry stage. The number of AWS recordings may be under-estimated if the action was taken but was not documented in the eMR by the clinicians.
The results may also be affected by the spectrum of alcohol-related morbidity that was manifested in the patient population and the clinical judgment used by the two medical officers who extracted data to determine if a specified management step was implemented or not.
Conclusion
This study identified gaps in the management of patients with AUD. It identified a need to routinely use an alcohol screening tool to screen patients at the initial presentation and to improve alcohol management of patients with AUD in the hospital. Future research is required to investigate why some patients with AUD were not referred to the DA-CL service and how to improve the management of these patients across the continuum of care.
